Found 7 matching trials
BMS-813160 With Nivolumab and Gemcitabine and Nab-paclitaxel in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
PHASE1The purpose of this research study is to learn more about a new combination...
Location
Washington University School of Medicine
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors
PHASE1The purpose of this study is to evaluate the safety profile, tolerability, ...
Location
Local Institution - 0003
Neoadjuvant Nivolumab With CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)
PHASE2The purpose of this research study is to study the effect of giving nivolum...
Location
Icahn School of Medicine at Mount Sinai
Single Ascending Dose (BMS-813160) Study
PHASE1The primary purpose of this study is to evaluate the safety and tolerabilit...
Location
Covance Clinical Research Unit, Inc.
A Study to Test Combination Treatments in People With Advanced Renal Cell Carcinoma
PHASE2The purpose of this study is to test the effectiveness and safety of variou...
Location
Local Institution - 0037
Trial of Neoadjuvant and Adjuvant Nivolumab and BMS-813160 With or Without GVAX for Locally Advanced Pancreatic Ductal Adenocarcinomas.
PHASE1The purpose of this study is to evaluate if the combination of nivolumab an...
Location
Sidney Kimmel Comprehensive Cancer Center
Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease
PHASE2The purpose of this study is to determine whether BMS-813160 will reduce th...